| Product Code: ETC11228026 | Publication Date: Apr 2025 | Updated Date: Apr 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
Zambia`s import of tyrosine kinase inhibitors in 2024 saw a notable increase in concentration among top exporting countries, with India, South Africa, China, USA, and Denmark leading the way. The high HHI concentration in 2023 persisted into 2024, indicating a competitive market landscape. Despite a modest compound annual growth rate (CAGR) of 0.24% from 2020 to 2024, the growth rate spiked by 21.93% from 2023 to 2024, suggesting a significant uptick in demand for these pharmaceutical products in Zambia.


1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Zambia Tyrosine Kinase Inhibitors Market Overview |
3.1 Zambia Country Macro Economic Indicators |
3.2 Zambia Tyrosine Kinase Inhibitors Market Revenues & Volume, 2022 & 2032F |
3.3 Zambia Tyrosine Kinase Inhibitors Market - Industry Life Cycle |
3.4 Zambia Tyrosine Kinase Inhibitors Market - Porter's Five Forces |
3.5 Zambia Tyrosine Kinase Inhibitors Market Revenues & Volume Share, By Type, 2022 & 2032F |
3.6 Zambia Tyrosine Kinase Inhibitors Market Revenues & Volume Share, By Application, 2022 & 2032F |
3.7 Zambia Tyrosine Kinase Inhibitors Market Revenues & Volume Share, By Distribution Channel, 2022 & 2032F |
3.8 Zambia Tyrosine Kinase Inhibitors Market Revenues & Volume Share, By End User, 2022 & 2032F |
3.9 Zambia Tyrosine Kinase Inhibitors Market Revenues & Volume Share, By Mode of Action, 2022 & 2032F |
4 Zambia Tyrosine Kinase Inhibitors Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer and other diseases that require tyrosine kinase inhibitors treatment in Zambia |
4.2.2 Growing awareness and adoption of targeted therapies in the healthcare sector |
4.2.3 Rise in healthcare expenditure and government initiatives to improve access to advanced treatments |
4.3 Market Restraints |
4.3.1 High cost associated with tyrosine kinase inhibitors limiting affordability for a significant portion of the population |
4.3.2 Limited healthcare infrastructure and resources in Zambia affecting the distribution and availability of these medications |
5 Zambia Tyrosine Kinase Inhibitors Market Trends |
6 Zambia Tyrosine Kinase Inhibitors Market, By Types |
6.1 Zambia Tyrosine Kinase Inhibitors Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Zambia Tyrosine Kinase Inhibitors Market Revenues & Volume, By Type, 2022 - 2032F |
6.1.3 Zambia Tyrosine Kinase Inhibitors Market Revenues & Volume, By Small Molecule TKIs, 2022 - 2032F |
6.1.4 Zambia Tyrosine Kinase Inhibitors Market Revenues & Volume, By Large Molecule TKIs, 2022 - 2032F |
6.1.5 Zambia Tyrosine Kinase Inhibitors Market Revenues & Volume, By Multi-Targeted TKIs, 2022 - 2032F |
6.1.6 Zambia Tyrosine Kinase Inhibitors Market Revenues & Volume, By Specific TKIs, 2022 - 2032F |
6.2 Zambia Tyrosine Kinase Inhibitors Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Zambia Tyrosine Kinase Inhibitors Market Revenues & Volume, By Oncology, 2022 - 2032F |
6.2.3 Zambia Tyrosine Kinase Inhibitors Market Revenues & Volume, By Inflammatory Diseases, 2022 - 2032F |
6.2.4 Zambia Tyrosine Kinase Inhibitors Market Revenues & Volume, By Cardiovascular, 2022 - 2032F |
6.2.5 Zambia Tyrosine Kinase Inhibitors Market Revenues & Volume, By Neurology, 2022 - 2032F |
6.3 Zambia Tyrosine Kinase Inhibitors Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Zambia Tyrosine Kinase Inhibitors Market Revenues & Volume, By Online Pharmacies, 2022 - 2032F |
6.3.3 Zambia Tyrosine Kinase Inhibitors Market Revenues & Volume, By Retail Pharmacies, 2022 - 2032F |
6.3.4 Zambia Tyrosine Kinase Inhibitors Market Revenues & Volume, By Direct Sales, 2022 - 2032F |
6.4 Zambia Tyrosine Kinase Inhibitors Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Zambia Tyrosine Kinase Inhibitors Market Revenues & Volume, By Hospitals, 2022 - 2032F |
6.4.3 Zambia Tyrosine Kinase Inhibitors Market Revenues & Volume, By Specialty Clinics, 2022 - 2032F |
6.4.4 Zambia Tyrosine Kinase Inhibitors Market Revenues & Volume, By Research Institutes, 2022 - 2032F |
6.5 Zambia Tyrosine Kinase Inhibitors Market, By Mode of Action |
6.5.1 Overview and Analysis |
6.5.2 Zambia Tyrosine Kinase Inhibitors Market Revenues & Volume, By Reversible, 2022 - 2032F |
6.5.3 Zambia Tyrosine Kinase Inhibitors Market Revenues & Volume, By Irreversible, 2022 - 2032F |
6.5.4 Zambia Tyrosine Kinase Inhibitors Market Revenues & Volume, By Others, 2022 - 2032F |
6.5.5 Zambia Tyrosine Kinase Inhibitors Market Revenues & Volume, By Others, 2022 - 2032F |
7 Zambia Tyrosine Kinase Inhibitors Market Import-Export Trade Statistics |
7.1 Zambia Tyrosine Kinase Inhibitors Market Export to Major Countries |
7.2 Zambia Tyrosine Kinase Inhibitors Market Imports from Major Countries |
8 Zambia Tyrosine Kinase Inhibitors Market Key Performance Indicators |
8.1 Patient adherence rate to tyrosine kinase inhibitors treatment |
8.2 Number of healthcare facilities offering tyrosine kinase inhibitors in Zambia |
8.3 Rate of successful treatment outcomes with tyrosine kinase inhibitors |
8.4 Percentage of healthcare professionals trained in the administration of tyrosine kinase inhibitors |
9 Zambia Tyrosine Kinase Inhibitors Market - Opportunity Assessment |
9.1 Zambia Tyrosine Kinase Inhibitors Market Opportunity Assessment, By Type, 2022 & 2032F |
9.2 Zambia Tyrosine Kinase Inhibitors Market Opportunity Assessment, By Application, 2022 & 2032F |
9.3 Zambia Tyrosine Kinase Inhibitors Market Opportunity Assessment, By Distribution Channel, 2022 & 2032F |
9.4 Zambia Tyrosine Kinase Inhibitors Market Opportunity Assessment, By End User, 2022 & 2032F |
9.5 Zambia Tyrosine Kinase Inhibitors Market Opportunity Assessment, By Mode of Action, 2022 & 2032F |
10 Zambia Tyrosine Kinase Inhibitors Market - Competitive Landscape |
10.1 Zambia Tyrosine Kinase Inhibitors Market Revenue Share, By Companies, 2025 |
10.2 Zambia Tyrosine Kinase Inhibitors Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here